Isosorbide dinitrate and Post procedural haemorrhage - a phase IV clinical study of FDA data

Summary:

Post procedural haemorrhage is reported as a side effect among people who take Isosorbide dinitrate (isosorbide dinitrate), especially for people who are male, 60+ old, also take Carvedilol, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Post procedural haemorrhage when taking Isosorbide dinitrate. It is created by eHealthMe based on reports of 13,073 people who have side effects when taking Isosorbide dinitrate from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Post procedural haemorrhage?

Post procedural haemorrhage (post procedural bleeding) is found to be associated with 665 drugs and 854 conditions by eHealthMe. Check the latest studies of Post procedural haemorrhage.

On Jul, 18, 2026

13,073 people reported to have side effects when taking Isosorbide dinitrate.
Among them, 15 people (0.11%) have Post procedural haemorrhage.

Could Isosorbide dinitrate cause Post procedural haemorrhage?

Among these 15 people:

What is the gender of people who have Post procedural haemorrhage when taking Isosorbide dinitrate? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Post procedural haemorrhage when taking Isosorbide dinitrate? *

What are other drugs people take besides Isosorbide dinitrate? *

What are other side effects people have besides Post procedural haemorrhage? *

Arrhythmias (irregular heartbeat): 4 people, 26.67%
Anal Fistula: 4 people, 26.67%
Road Traffic Accident: 4 people, 26.67%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 3 people, 20.00%
Shunt Stenosis (narrowing of shunt): 3 people, 20.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 3 people, 20.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
Nausea And Vomiting: 3 people, 20.00%
Coronary Artery Stenosis (narrowing of coronary artery): 3 people, 20.00%
Chest Pain: 3 people, 20.00%

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 5 people, 33.33%
Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 20.00%
Itching: 3 people, 20.00%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 20.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 20.00%
Diabetes: 3 people, 20.00%
Carnitine Deficiency: 3 people, 20.00%
Insomnia (sleeplessness): 2 people, 13.33%
Sleep Disorder: 1 person, 6.67%
Constipation: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and have Post procedural haemorrhage?

- Check whether Post procedural haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isosorbide dinitrate:

Isosorbide dinitrate (13,180 reports)

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (665 drugs)

Browse all the conditions that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (854 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate (the active ingredients of Isosorbide dinitrate) and Isosorbide dinitrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.